Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 97 Records) |
| Query Trace: Pain and CYP2D6[original query] |
|---|
| Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare Costs. Journal of personalized medicine 2021 Nov 11 (11): . Michaud Veronique, Bikmetov Ravil, Smith Matt K, Dow Pamela, Darakjian Lucy I, Deodhar Malavika, Cicali Brian, Bain Kevin T, Turgeon Jacqu |
| Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism. Pharmaceutics 2021 Sep 13 (9): . Deodhar Malavika, Turgeon Jacques, Michaud Veroniq |
| The Role of Pharmacogenomics in Postoperative Pain Management. Methods in molecular biology (Clifton, N.J.) 2022 9 2547 505-526. Sachtleben E Paylor, Rooney Kelsey, Haddad Hannah, Lassiegne Victoria L, Boudreaux Megan, Cornett Elyse M, Kaye Alan |
| Detection of relevant pharmacogenetic information through exome sequencing in oncology. Pharmacogenomics 2022 8 23 (14): 759-770. Verdez Simon, Albuisson Juliette, Duffourd Yannis, Boidot Romain, Reda Manon, Thauvin-Robinet Christel, Fumet Jean-David, Ladoire Sylvain, Nambot Sophie, Callier Patrick, Faivre Laurence, Ghiringhelli François, Picard Nicol |
| Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review. Pharmaceutics 2022 6 14 (6): . Zobdeh Farzin, Eremenko Ivan I, Akan Mikail A, Tarasov Vadim V, Chubarev Vladimir N, Schiöth Helgi B, Mwinyi Jessi |
| CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia. Expert opinion on drug metabolism & toxicology 2022 6 18 (4): 261-275. Ballester Pura, Muriel Javier, Peiró Ana |
| The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug metabolism and personalized therapy 2022 4 37 (1): 27-34. Muradian Andranik Alexandrovich, Sychev Dmitry Alekseevich, Blagovestnov Dmitry Alekseevich, Sozaeva Zhannet Alimovna, Akmalova Kristina Anatolyevna, Zastrozhin Michael Sergeevich, Kerimova Leyla Nabievna, Koroshvili Vadim Teymurazovich, Epifanova Irina Alexandrov |
| Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota. The pharmacogenomics journal 2022 Jan . Lopes Guilherme S, Lopes Jaime L, Bielinski Suzette J, Armasu Sebastian M, Zhu Ye, Cavanaugh Dana C, Moyer Ann M, Jacobson Debra J, Wang Liwei, Jiang Ruoxiang, St Sauver Jennifer L, Larson Nicholas |
| The Effect of Genetic Variation on the Sensitivity to Opioid Analgesics in Patients With Postoperative Pain: An Updated Meta-analysis. Pain physician 2023 9 26 (5): E467-E485. Zhi-Xue Li, Feng Ye, Wen-Yao Li, Yan-Ping Bao, Yin-Chu Cheng, Zai-Wei Song, Rong-Sheng Zhao, Zhen-Yu R |
| CYP2D6-guided opioid therapy for adults with cancer pain: a randomized implementation clinical trial. Pharmacotherapy 2023 9 . Scott A Mosley, Emily Cicali, Alex Del Cueto, Diane G Portman, Kristine A Donovan, Yan Gong, Taimour Langaee, Priya Gopalan, Jessica Schmit, Jason S Starr, Natalie Silver, Young D Chang, Sahana Rajasekhara, Joshua E Smith, Heloisa P Soares, Mike Clare-Salzler, Petr Starostik, Thomas J George, Howard L McLeod, Roger B Fillingim, J Kevin Hicks, Larisa H Cavalla |
| The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation. Pharmacy (Basel, Switzerland) 2023 8 11 (4): . Alexandra Brady, Suman Misra, Mina Abdelmalek, Adrijana Kekic, Katie Kunze, Elisabeth Lim, Nicholas Jakob, Girish Mour, Mira T Kedd |
| Decreased Analgesic Effect of Tramadol in Japanese Patients with CYP2D6 Intermediate Metabolizers after Orthopedic Surgery. Biological & pharmaceutical bulletin 2023 7 46 (7): 907-913. Takaki Kamiya, Daiki Hira, Ryo Nakajima, Kazuha Shinoda, Atsuko Motomochi, Aya Morikochi, Yoshito Ikeda, Tetsuichiro Isono, Michiya Akabane, Satoshi Ueshima, Mikio Kakumoto, Shinji Imai, Shin-Ya Morita, Tomohiro Tera |
| Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy 2023 7 . Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ily |
| Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study. International journal of molecular sciences 2023 7 24 (13): . Laura Agulló, Isidro Aguado, Javier Muriel, César Margarit, Alba Gómez, Mónica Escorial, Astrid Sánchez, Alicia Fernández, Ana M Pei |
| Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. Acta pharmaceutica (Zagreb, Croatia) 2023 6 73 (2): 227-241. Javier Muriel, Mónica Escorial, César Margarit, Jordi Barrachina, Cristian Carvajal, Domingo Morales, Ana M Pei |
A brain-wide genome-wide association study of candidate quantitative trait loci associated with structural and functional phenotypes of pain sensitivity.
Cerebral cortex (New York, N.Y. : 1991) 2023 3 . Zhang Li, Pan Yiwen, Huang Gan, Liang Zhen, Li Linling, Zhang Min, Zhang Zhig |
| Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 2023 2 15 (2): . Soria-Chacartegui Paula, Zubiaur Pablo, Ochoa Dolores, Villapalos-García Gonzalo, Román Manuel, Matas Miriam, Figueiredo-Tor Laura, Mejía-Abril Gina, Calleja Sofía, de Miguel Alejandro, Navares-Gómez Marcos, Martín-Vilchez Samuel, Abad-Santos Francis |
| Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions. Neurogastroenterology and motility 2023 12 e14722. Revati Varma, Jeffrey P Staab, Eric T Matey, Jessica A Wright, Brototo Deb, Konstantinos N Lazaridis, Lawrence A Szarka, Kent R Bailey, Adil E Bharuc |
| Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone. Pain reports 2023 11 8 (6): e1113. Samina Ali, Aran Yukseloglu, Colin J Ross, Rhonda J Rosychuk, Amy L Drendel, Robin Manaloor, David W Johnson, Sylvie Le May, Bruce Carlet |
| Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study. BMC pharmacology & toxicology 2023 11 24 (1): 64. Jing Yang, Ying-Zi Sun, Qun-Fang Li, Zheng Fu, Yu-Yao Guan, Chao Song, Lei Zhe |
| Association of CYP2D6 genotype predicted phenotypes with oxycodone requirements and side effects in children undergoing surgery. Annals of translational medicine 2023 1 10 (23): 1262. Merchant Soroush, Prows Cynthia A, Yang Fang, Ding Lili, MacDonald Jacob, Zhang Xue, Sadhasivam Senthilkumar, Garcia Victor, Sturm Peter, Chidambaran Vid |
| Fentanyl dosage for preterm infants suggested by a pharmacokinetic, -dynamic, and -genetic model. Pediatric research 2024 7 . Maddlie Bardol, Elisabeth Norman, Hugo Lagercrantz, Vineta Fellman, Joseph F Standi |
| Physiologically based pharmacokinetic modeling to predict the pharmacokinetics of codeine in different CYP2D6 phenotypes. Frontiers in pharmacology 2024 5 15 1342515. Yujie Yang, Xiqian Zhang, Yirong Wang, Heng Xi, Min Xu, Liang Zhe |
| Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach. Minerva anestesiologica 2024 4 . Mónica Escorial, Javier Muriel, Laura Agulló, Thomas Zandonai, César Margarit, Domingo Morales, Ana M Pei |
| Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer? Pharmacogenomics 2024 12 1-8. Aaron K Wong, Sara Vogrin, Pal Klepstad, Justin Rubio, Brian Le, Jennifer Philip, Andrew A Somog |
| Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair - a prospective study protocol. BMC medical genomics 2024 12 17 (1): 286. Florine M Wiss, Ulrich Dietz, Andreas Thalheimer, Sebastian Lamm, Robert Rosenberg, Samuel S Allemann, Henriette E Meyer Zu Schwabedissen, Anna Bollinger, Markus L Lampe |
| Does cytochrome 2D6 genotype affect the analgesic efficacy of codeine after ambulatory surgery? Prospective trial in 987 adults. Acta anaesthesiologica Scandinavica 2024 11 69 (1): e14549. Satu Poikola, Hanna von Plato, Jukka Harju, Johanna I Kiiski, Kristiina Mattila, Klaus T Olkkola, Mikko Niemi, Eija Kalso, Vesa Kontin |
| Providers' use of pharmacogenetic testing to inform opioid prescribing among veterans. Pharmacogenomics 2024 10 1-7. Rachele K Lipsky, Catherine Chanfreau-Coffinier, Deepak Voora, Jodie Trafton, Charlotte Williams, Susana B Martins, Sumitra Muralidhar, David W Osl |
| Evaluation of the effect of CYP2D6 and OCT1 polymorphisms on the pharmacokinetics of tramadol: Implications for clinical safety and dose rationale in paediatric chronic pain. British journal of clinical pharmacology 2024 10 . Paul Healy, Karel Allegaert, Oscar Della Pasq |
| Pharmacogenetics of opioid medications for relief of labor pain and post-cesarean pain: a systematic review and meta-analysis. European journal of clinical pharmacology 2025 1 . Martina Giacon, Sarah Cargnin, Maria Talmon, Salvatore Terrazzi |
- Page last reviewed:Feb 1, 2024
- Content source: